{"id":"https://openalex.org/W2056835378","doi":"https://doi.org/10.1007/s11060-011-0717-z","title":"Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma","display_name":"Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma","publication_year":2011,"publication_date":"2011-10-07","ids":{"openalex":"https://openalex.org/W2056835378","doi":"https://doi.org/10.1007/s11060-011-0717-z","mag":"2056835378","pmid":"https://pubmed.ncbi.nlm.nih.gov/21984064"},"language":"en","primary_location":{"id":"doi:10.1007/s11060-011-0717-z","doi":"https://doi.org/10.1007/s11060-011-0717-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11060-011-0717-z","pdf_url":null,"source":{"id":"https://openalex.org/S175922936","display_name":"Journal of Neuro-Oncology","issn_l":"0167-594X","issn":["0167-594X","1573-7373"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091053515","display_name":"Jan Drappatz","orcid":"https://orcid.org/0000-0001-8187-7119","observed_orcids":["https://orcid.org/0000-0001-8187-7119"]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Drappatz","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035087247","display_name":"Eudocia Q. Lee","orcid":"https://orcid.org/0000-0003-3355-5179","observed_orcids":["https://orcid.org/0000-0003-3355-5179"]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Q. Lee","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Hammond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Hammond","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041824343","display_name":"Sean Aaron Grimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. A. Grimm","raw_affiliation_strings":["Northwestern University, Chicago, IL, USA","Northwestern University****"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]},{"raw_affiliation_string":"Northwestern University****","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029013340","display_name":"Andrew David Norden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. D. Norden","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041980697","display_name":"Rameen Beroukhim","orcid":"https://orcid.org/0000-0001-6303-3609","observed_orcids":["https://orcid.org/0000-0001-6303-3609","https://orcid.org/0000-0002-5506-0575"]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Beroukhim","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112095475","display_name":"Mary Gerard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Gerard","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023905352","display_name":"David Schiff","orcid":"https://orcid.org/0000-0002-1896-2502","observed_orcids":["https://orcid.org/0000-0002-1896-2502","https://orcid.org/0000-0003-1561-9220"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Schiff","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA","University of Virginia'"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]},{"raw_affiliation_string":"University of Virginia'","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111491988","display_name":"A. S.","orcid":"https://orcid.org/0009-0005-0260-1939","observed_orcids":["https://orcid.org/0009-0005-0260-1939"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. S. Chi","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA","Massachusetts General Hospital - Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Massachusetts General Hospital - Boston, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069527451","display_name":"Tracy T. Batchelor","orcid":"https://orcid.org/0000-0001-7568-6607","observed_orcids":["https://orcid.org/0000-0001-7568-6607"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. T. Batchelor","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA","Massachusetts General Hospital - Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Massachusetts General Hospital - Boston, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001181010","display_name":"Lisa M. Doherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. M. Doherty","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086484023","display_name":"Abigail Slate Ciampa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. S. Ciampa","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074469073","display_name":"D. C. LaFrankie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. C. LaFrankie","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005718725","display_name":"Sandra F. Ruland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Ruland","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109111220","display_name":"Susan M. Snodgrass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. M. Snodgrass","raw_affiliation_strings":["Novartis Pharmaceuticals, East Hanover, NJ, USA","Novartis Pharmaceuticals; East Hanover USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, East Hanover, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals; East Hanover USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029952866","display_name":"Jeffrey J. Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. Raizer","raw_affiliation_strings":["Northwestern University, Chicago, IL, USA","Northwestern University Chicago, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]},{"raw_affiliation_string":"Northwestern University Chicago, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021656597","display_name":"Patrick Yung Wen","orcid":"https://orcid.org/0000-0002-0774-7700","observed_orcids":["https://orcid.org/0000-0002-0774-7700","https://orcid.org/0000-0003-3224-3042","https://orcid.org/0000-0002-2452-0540"]},"institutions":[{"id":"https://openalex.org/I4210102457","display_name":"Center for Neuro-Oncology","ror":"https://ror.org/00z2tp793","country_code":"US","type":"facility","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210102457","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P. Y. Wen","raw_affiliation_strings":["Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuro-Oncology, Dana Farber/Brigham and Women\u2019s Cancer Center, 450 Brookline Avenue, SW 430, Boston, MA, 02215, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Center for Neuro-Oncology, Dana-Farber/Brigham & Women\u2019s Cancer Center, Boston, USA","institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5021656597"],"corresponding_institution_ids":["https://openalex.org/I4210102457","https://openalex.org/I4210161994"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":3.9767,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.93812275,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"107","issue":"1","first_page":"133","last_page":"138"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/recurrent-high-grade-glioma","display_name":"recurrent high-grade glioma","score":0.996999979019165},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/vegf-inhibitors","display_name":"VEGF inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8330000042915344},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7839999794960022},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8849999904632568},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.9427831172943115},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9131054878234863},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8102763891220093},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6541576385498047},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6362707614898682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5448065996170044},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5042403936386108},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42948102951049805},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39110249280929565},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3649572730064392},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30662742257118225},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2403917908668518},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077767","descriptor_name":"Panobinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11060-011-0717-z","doi":"https://doi.org/10.1007/s11060-011-0717-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11060-011-0717-z","pdf_url":null,"source":{"id":"https://openalex.org/S175922936","display_name":"Journal of Neuro-Oncology","issn_l":"0167-594X","issn":["0167-594X","1573-7373"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuro-Oncology","raw_type":"journal-article"},{"id":"pmid:21984064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21984064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neuro-oncology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1980275866","https://openalex.org/W2013848847","https://openalex.org/W2021379061","https://openalex.org/W2021577923","https://openalex.org/W2031671750","https://openalex.org/W2036044314","https://openalex.org/W2050969887","https://openalex.org/W2052227923","https://openalex.org/W2056918364","https://openalex.org/W2063622451","https://openalex.org/W2069341069","https://openalex.org/W2089913110","https://openalex.org/W2090465622","https://openalex.org/W2093783077","https://openalex.org/W2094726890","https://openalex.org/W2100337624","https://openalex.org/W2102428449","https://openalex.org/W2105431194","https://openalex.org/W2114468318","https://openalex.org/W2132697290","https://openalex.org/W2132880072","https://openalex.org/W2147535764","https://openalex.org/W2162643152","https://openalex.org/W2169424184","https://openalex.org/W2170367762","https://openalex.org/W2171141282","https://openalex.org/W2551516693"],"related_works":["https://openalex.org/W2589182611","https://openalex.org/W2037507788","https://openalex.org/W2599208091","https://openalex.org/W2048565648","https://openalex.org/W2599570809","https://openalex.org/W1183502158","https://openalex.org/W4389451191","https://openalex.org/W2781261700","https://openalex.org/W3101467937","https://openalex.org/W2260733053"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}